Skip to main content
. 2016 Oct;101(10):1200–1207. doi: 10.3324/haematol.2016.144949

Figure 3.

Figure 3.

Metabolic effects of nilotinib by time. (A) Distribution of fasting glucose at milestones; (B) Distribution of glycated hemoglobin at milestones; (C) Distribution of triglycerides at milestones; (D) Distribution of total cholesterol at milestones; (E) Distribution of low density lipoprotein at milestones; (F) Distribution of high density lipoprotein at milestones.